ArticleHuman gene therapy2021

A Cautiously Optimistic Outlook of a Designer Therapy for 1% of Duchenne Muscular Dystrophy Patients.

Dongsheng DuanPubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.